International Bio Services Co., Ltd. (IBS) is a contract research organization affiliated of Mahidol University, established in 2005. IBS is dedicatedly focused on bringing up the highest quality of one-stop services in bioequivalence study to our clients worldwide.

With over hundreds of bioequivalence studies conducted. IBS has built a brand of excellence in the conduct of Bioequivalence (BE) and Bioavailability (BA) studies to support registration of generic pharmaceuticals.

In 2010, we are the first bioequivalence center in Thailand that received GLP accreditation from Thai regulatory authority and regularly inspection.

In 2014, IBS was inspected and approved with regularly audited by National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health, Malaysia.

At the present, we are the largest and one of most technologically advanced bioequivalence center in Thailand. All operations are performed in according with ICH-GCP guideline and OECD-GLP principles as well as local and international regulations.